Drugs / brain natriuretic peptide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00953472 | Feb 2009 → Apr 2011 | hypertensive disorder | Mayo Clinic | Terminated | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT01413542 Comparator | Nov 2011 → Jul 2013 | hypertensive disorder, type 2 diabetes mellitus | Vanderbilt University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | brain natriuretic peptide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01413542 ↗ |
| Modality | Peptide | “two peptide hormones - atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP)” NCT00953472 ↗ |